Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods.

by Bouchet, C., Spyratos, F., Hacène, K., Durcos, L., Bécette, V., Oglobine, J.
Published 1998

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

by Bouchet, C., Spyratos, F., Martin, P. M., Hacène, K., Gentile, A., Oglobine, J.
Published 1994

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

by Foucré, D., Bouchet, C., Hacène, K., Pourreau-Schneider, N., Gentile, A., Martin, P. M., Desplaces, A., Oglobine, J.
Published 1991